Pre-solicitationPosted Sep 9, 2026·Responses due Sep 18, 2026

Deep Ultraviolet (DUV) 320 nm Laser for High-Dimensional Flow Cytometry.

National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
334516
Value
Not stated
Solicitation
75N98026Q01174
Set-aside
None stated
PSC
6640
Place
Bethesda, MD, USA
Contact
Trish Haun (haunp@mail.nih.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 75N98026Q01174 in this department, oldest first.

Early notice
  • Sep 9, 2026 · this notice
    Pre-solicitation
Solicitation
None posted
Award
Not yet. Typical award: Oct 19, 2026 to Jul 11, 2027, middle of the range Nov 12, 2026.
Measured from 68 past early notices at National Institutes of Health that later posted an award (middle half of cases, counted from Sep 9, 2026).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

The National Institutes of Health (NIH) intends to award a Firm-Fixed-Price Purchase Order to Coherent Corporation for a Deep Ultraviolet (DUV) 320 nm Laser for High-Dimensional Flow Cytometry. The LP Research Flow Cytometry Facility provides essential cell sorting and flow cytometry analysis services to the Experimental Transplantation and Immunotherapy Branch and other branches and programs within the Center for Cancer Research (CCR). The required 320 nm deep ultraviolet laser is necessary to upgrade existing high-dimensional flow cytometers and enable excitation of deep-ultraviolet fluoresc… (show all)

ent probes. The laser will expand the laboratory's high-dimensional analysis capabilities without requiring the purchase of an entirely new flow cytometer. The unit must be capable of installation and use with the laboratory's existing Cytek spectral, LSR II, LSR Fortessa, and Influx flow cytometers, as applicable. The expanded capability will support validation of deep-ultraviolet fluorochromes, their integration into existing panels, and their continued use in research applications. The Government intends to solicit from a single source in accordance with FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements. Based on the proprietary nature, unique configuration, and compatibility requirements of the equipment, Coherent Corporation is the only known responsible source capable of providing the required laser without substantial duplication of cost or unacceptable delay. This notice is not a request for competitive quotations. However, interested parties that believe they are capable of meeting the Government's requirements may submit a capability statement demonstrating their ability to provide the required 320 nm deep ultraviolet laser and meet the Government's technical and compatibility requirements. The Government will consider all timely responses received and determine whether the acquisition should proceed as a sole-source procurement or be competed. The Government anticipates making an award approximately five (5) calendar days after the closing date of this notice, unless the Government determines that another responsible source is capable of meeting the requirement. Capability statements shall be submitted electronically to haunp@mail.nih.gov no later than 9:00 a.m. EDT on September 18, 2026. Please reference Notice No. 75N98026Q01174 in the subject line of the response.

Who won similar work

10 award notices on SAM.gov in the last 24 months. Matched by: Same office (NATIONAL INSTITUTES OF HEALTH OLAO), same product/service code (PSC) 6640 and NAICS 334516.

Single-winner award sizes (10): middle half $37K to $188K, median $61K; range $21K to $230K.

WinnerAwardsValueLast
BRUKER NANO, INC · $BRKR · $3.5B1$230KAug 14, 2026
Sony Biotechnology Inc.1$227KAug 17, 2026
NEWPORT CORP1$212KJul 8, 2026
AMUZA INC.1$115KJul 10, 2026
PARSE BIOSCIENCES, INC.1$67KJul 8, 2026
Mirion Technologies (Capintec), Inc.1$56KJun 29, 2026
NIKON INSTRUMENTS INC1$40KSep 25, 2026
SR RESEARCH LIMITED1$37KJul 8, 2026
BECKMAN COULTER, INC1$31KJul 10, 2026
Revvity Health Sciences, Inc.1$21KOct 9, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

Investor context
  • $BRKR reported $3.5B revenue (12 months to Jun 30, 2026). The median single-winner award in these 10 past awards, $61K, is under 0.1% of that. SEC filing

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
  • 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 1 of the past winners are listed companies
  • 0 insider buys and 0 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.